Five factor model of schizophrenia: Replication across samples
In order to examine the effect of neuroleptic medication on the factor structure of schizophrenic symptomatology, 517 DSM-III-R schizophrenic in-patients enrolled in a multicenter phase II drug study were evaluated on their pre-existing neuroleptic at screening on the Positive and Negative Syndrome...
Gespeichert in:
Veröffentlicht in: | Schizophrenia research 1995-02, Vol.14 (3), p.229-234 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 234 |
---|---|
container_issue | 3 |
container_start_page | 229 |
container_title | Schizophrenia research |
container_volume | 14 |
creator | Lindenmayer, Jean-Pierre Grochowski, Sandra Hyman, Ruth B. |
description | In order to examine the effect of neuroleptic medication on the factor structure of schizophrenic symptomatology, 517 DSM-III-R schizophrenic in-patients enrolled in a multicenter phase II drug study were evaluated on their pre-existing neuroleptic at screening on the Positive and Negative Syndrome Scale (PANSS) and after a one-week drugfree period. Separate principal components analyses of the PANSS were done at each time point. PANSS total and component scores were assessed for differences utilizing paired
t-tests. Both factor analyses confirmed the five factor model (negative, positive, cognitive, excitement and depression components) explaining 51.7 and 56.2% of the variances at each time point. After medication wash-out psychopathology significantly worsened as measured by total PANSS score and by each of the components. The overall worsening of component scores appeared global and uniform, as evidenced by the fact that at washout, the proportion of individual component scores to total psychopathology remained constant for most components. The lack of change of most components in proportion to the psychopathology total is evidence for the stability of these individual psychopathological dimensions of patients while on and off neuroleptics. The results further support the validity of the five-factor model of schizophrenic psychopathology as measured by the PANSS. |
doi_str_mv | 10.1016/0920-9964(94)00041-6 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77291284</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0920996494000416</els_id><sourcerecordid>77291284</sourcerecordid><originalsourceid>FETCH-LOGICAL-c367t-df409650797b71e0f6f461f55c065bdbcd579abe5c765c2be08c1a7a169113683</originalsourceid><addsrcrecordid>eNp9kF1LwzAUhoMoc378A4VeiOhFNWnzsXgxkOFUGAii1yFNT1ikbWrSDfTX221ll16di_c557w8CF0QfEcw4fdYZjiVktMbSW8xxpSk_ACNCRN5mjEsD9F4jxyjkxi_eogwLEZoJATnLKdjNJ27NSRWm86HpPYlVIm3STRL9-vbZYDG6YfkHdrKGd053yTaBB9jEnXdVhDP0JHVVYTzYZ6iz_nTx-wlXbw9v84eF6nJuejS0lIsef9aikIQwJZbyollzGDOirIwJRNSF8CM4MxkBeCJIVpowiUhOZ_kp-h6d7cN_nsFsVO1iwaqSjfgV1EJkUmSTWgP0h24rRnAqja4WocfRbDaaFMbJ2rjREmqttoU79cuh_urooZyvzR46vOrIdfR6MoG3RgX91ieSyqk7LHpDoPexdpBUNE4aAyULoDpVOnd_z3-AIlBh_w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77291284</pqid></control><display><type>article</type><title>Five factor model of schizophrenia: Replication across samples</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Lindenmayer, Jean-Pierre ; Grochowski, Sandra ; Hyman, Ruth B.</creator><creatorcontrib>Lindenmayer, Jean-Pierre ; Grochowski, Sandra ; Hyman, Ruth B.</creatorcontrib><description>In order to examine the effect of neuroleptic medication on the factor structure of schizophrenic symptomatology, 517 DSM-III-R schizophrenic in-patients enrolled in a multicenter phase II drug study were evaluated on their pre-existing neuroleptic at screening on the Positive and Negative Syndrome Scale (PANSS) and after a one-week drugfree period. Separate principal components analyses of the PANSS were done at each time point. PANSS total and component scores were assessed for differences utilizing paired
t-tests. Both factor analyses confirmed the five factor model (negative, positive, cognitive, excitement and depression components) explaining 51.7 and 56.2% of the variances at each time point. After medication wash-out psychopathology significantly worsened as measured by total PANSS score and by each of the components. The overall worsening of component scores appeared global and uniform, as evidenced by the fact that at washout, the proportion of individual component scores to total psychopathology remained constant for most components. The lack of change of most components in proportion to the psychopathology total is evidence for the stability of these individual psychopathological dimensions of patients while on and off neuroleptics. The results further support the validity of the five-factor model of schizophrenic psychopathology as measured by the PANSS.</description><identifier>ISSN: 0920-9964</identifier><identifier>EISSN: 1573-2509</identifier><identifier>DOI: 10.1016/0920-9964(94)00041-6</identifier><identifier>PMID: 7766534</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Adult ; Adult and adolescent clinical studies ; Age of Onset ; Biological and medical sciences ; Double-Blind Method ; Factor Analysis, Statistical ; Female ; Humans ; Male ; Medical sciences ; Placebos ; Positive and negative symptoms ; Psychiatric Status Rating Scales ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Psychoses ; Reproducibility of Results ; Schizophrenia ; Schizophrenia - diagnosis ; Schizophrenic Psychology</subject><ispartof>Schizophrenia research, 1995-02, Vol.14 (3), p.229-234</ispartof><rights>1995</rights><rights>1995 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c367t-df409650797b71e0f6f461f55c065bdbcd579abe5c765c2be08c1a7a169113683</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0920-9964(94)00041-6$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27922,27923,45993</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3394799$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7766534$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lindenmayer, Jean-Pierre</creatorcontrib><creatorcontrib>Grochowski, Sandra</creatorcontrib><creatorcontrib>Hyman, Ruth B.</creatorcontrib><title>Five factor model of schizophrenia: Replication across samples</title><title>Schizophrenia research</title><addtitle>Schizophr Res</addtitle><description>In order to examine the effect of neuroleptic medication on the factor structure of schizophrenic symptomatology, 517 DSM-III-R schizophrenic in-patients enrolled in a multicenter phase II drug study were evaluated on their pre-existing neuroleptic at screening on the Positive and Negative Syndrome Scale (PANSS) and after a one-week drugfree period. Separate principal components analyses of the PANSS were done at each time point. PANSS total and component scores were assessed for differences utilizing paired
t-tests. Both factor analyses confirmed the five factor model (negative, positive, cognitive, excitement and depression components) explaining 51.7 and 56.2% of the variances at each time point. After medication wash-out psychopathology significantly worsened as measured by total PANSS score and by each of the components. The overall worsening of component scores appeared global and uniform, as evidenced by the fact that at washout, the proportion of individual component scores to total psychopathology remained constant for most components. The lack of change of most components in proportion to the psychopathology total is evidence for the stability of these individual psychopathological dimensions of patients while on and off neuroleptics. The results further support the validity of the five-factor model of schizophrenic psychopathology as measured by the PANSS.</description><subject>Adult</subject><subject>Adult and adolescent clinical studies</subject><subject>Age of Onset</subject><subject>Biological and medical sciences</subject><subject>Double-Blind Method</subject><subject>Factor Analysis, Statistical</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Placebos</subject><subject>Positive and negative symptoms</subject><subject>Psychiatric Status Rating Scales</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Psychoses</subject><subject>Reproducibility of Results</subject><subject>Schizophrenia</subject><subject>Schizophrenia - diagnosis</subject><subject>Schizophrenic Psychology</subject><issn>0920-9964</issn><issn>1573-2509</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kF1LwzAUhoMoc378A4VeiOhFNWnzsXgxkOFUGAii1yFNT1ikbWrSDfTX221ll16di_c557w8CF0QfEcw4fdYZjiVktMbSW8xxpSk_ACNCRN5mjEsD9F4jxyjkxi_eogwLEZoJATnLKdjNJ27NSRWm86HpPYlVIm3STRL9-vbZYDG6YfkHdrKGd053yTaBB9jEnXdVhDP0JHVVYTzYZ6iz_nTx-wlXbw9v84eF6nJuejS0lIsef9aikIQwJZbyollzGDOirIwJRNSF8CM4MxkBeCJIVpowiUhOZ_kp-h6d7cN_nsFsVO1iwaqSjfgV1EJkUmSTWgP0h24rRnAqja4WocfRbDaaFMbJ2rjREmqttoU79cuh_urooZyvzR46vOrIdfR6MoG3RgX91ieSyqk7LHpDoPexdpBUNE4aAyULoDpVOnd_z3-AIlBh_w</recordid><startdate>199502</startdate><enddate>199502</enddate><creator>Lindenmayer, Jean-Pierre</creator><creator>Grochowski, Sandra</creator><creator>Hyman, Ruth B.</creator><general>Elsevier B.V</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199502</creationdate><title>Five factor model of schizophrenia: Replication across samples</title><author>Lindenmayer, Jean-Pierre ; Grochowski, Sandra ; Hyman, Ruth B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c367t-df409650797b71e0f6f461f55c065bdbcd579abe5c765c2be08c1a7a169113683</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Adult</topic><topic>Adult and adolescent clinical studies</topic><topic>Age of Onset</topic><topic>Biological and medical sciences</topic><topic>Double-Blind Method</topic><topic>Factor Analysis, Statistical</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Placebos</topic><topic>Positive and negative symptoms</topic><topic>Psychiatric Status Rating Scales</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Psychoses</topic><topic>Reproducibility of Results</topic><topic>Schizophrenia</topic><topic>Schizophrenia - diagnosis</topic><topic>Schizophrenic Psychology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lindenmayer, Jean-Pierre</creatorcontrib><creatorcontrib>Grochowski, Sandra</creatorcontrib><creatorcontrib>Hyman, Ruth B.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Schizophrenia research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lindenmayer, Jean-Pierre</au><au>Grochowski, Sandra</au><au>Hyman, Ruth B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Five factor model of schizophrenia: Replication across samples</atitle><jtitle>Schizophrenia research</jtitle><addtitle>Schizophr Res</addtitle><date>1995-02</date><risdate>1995</risdate><volume>14</volume><issue>3</issue><spage>229</spage><epage>234</epage><pages>229-234</pages><issn>0920-9964</issn><eissn>1573-2509</eissn><abstract>In order to examine the effect of neuroleptic medication on the factor structure of schizophrenic symptomatology, 517 DSM-III-R schizophrenic in-patients enrolled in a multicenter phase II drug study were evaluated on their pre-existing neuroleptic at screening on the Positive and Negative Syndrome Scale (PANSS) and after a one-week drugfree period. Separate principal components analyses of the PANSS were done at each time point. PANSS total and component scores were assessed for differences utilizing paired
t-tests. Both factor analyses confirmed the five factor model (negative, positive, cognitive, excitement and depression components) explaining 51.7 and 56.2% of the variances at each time point. After medication wash-out psychopathology significantly worsened as measured by total PANSS score and by each of the components. The overall worsening of component scores appeared global and uniform, as evidenced by the fact that at washout, the proportion of individual component scores to total psychopathology remained constant for most components. The lack of change of most components in proportion to the psychopathology total is evidence for the stability of these individual psychopathological dimensions of patients while on and off neuroleptics. The results further support the validity of the five-factor model of schizophrenic psychopathology as measured by the PANSS.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>7766534</pmid><doi>10.1016/0920-9964(94)00041-6</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0920-9964 |
ispartof | Schizophrenia research, 1995-02, Vol.14 (3), p.229-234 |
issn | 0920-9964 1573-2509 |
language | eng |
recordid | cdi_proquest_miscellaneous_77291284 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Adult Adult and adolescent clinical studies Age of Onset Biological and medical sciences Double-Blind Method Factor Analysis, Statistical Female Humans Male Medical sciences Placebos Positive and negative symptoms Psychiatric Status Rating Scales Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Psychoses Reproducibility of Results Schizophrenia Schizophrenia - diagnosis Schizophrenic Psychology |
title | Five factor model of schizophrenia: Replication across samples |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T11%3A59%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Five%20factor%20model%20of%20schizophrenia:%20Replication%20across%20samples&rft.jtitle=Schizophrenia%20research&rft.au=Lindenmayer,%20Jean-Pierre&rft.date=1995-02&rft.volume=14&rft.issue=3&rft.spage=229&rft.epage=234&rft.pages=229-234&rft.issn=0920-9964&rft.eissn=1573-2509&rft_id=info:doi/10.1016/0920-9964(94)00041-6&rft_dat=%3Cproquest_cross%3E77291284%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77291284&rft_id=info:pmid/7766534&rft_els_id=0920996494000416&rfr_iscdi=true |